Evaluation of growth hormone secretion and treatment. - sprookjes - yvandenbroek - TriplyDB

Evaluation of growth hormone secretion and treatment.

Evaluation of growth hormone secretion and treatment.

http://www.wikidata.org/entity/Q35354287

about

The GH/IGF-1 Axis and Heart Failure.Reduced levels of growth hormone, insulin-like growth factor-I and binding protein-3 in patients with shunted hydrocephalus.Minor head injury.

P2860

Q33654009-A0FB054C-ADF5-4B36-B3CC-CCC4102C2179 Q35255932-74ED8231-AAF8-473F-A3E2-0B5EA6D6F42B Q41582248-51F9AE42-0D0F-40D7-AE35-F9DB96AFDB05

P2860

Evaluation of growth hormone secretion and treatment.

http://www.wikidata.org/entity/Q35354287

description

1992 nî lūn-bûn

@nan

1992 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1992 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

name

Evaluation of growth hormone secretion and treatment.

@ast

Evaluation of growth hormone secretion and treatment.

@en

type

label

Evaluation of growth hormone secretion and treatment.

@ast

Evaluation of growth hormone secretion and treatment.

@en

prefLabel

Evaluation of growth hormone secretion and treatment.

@ast

Evaluation of growth hormone secretion and treatment.

@en

P1433

Q35354287-A7F5B5A8-452C-402B-AE1E-4A4172042271

P1476

Q35354287-BE02AF5D-9435-4293-9DBD-65AE09C8AE11

P2093

Q35354287-E9694640-03EC-4192-AF8D-160BC1F24020

P2860

Q35354287-05B43931-9079-499A-B774-DE3B8D7CA633

Q35354287-173728FD-CEE9-4296-85B2-A9A1D44FB97C

Q35354287-174DA128-886D-4280-8D5F-466C534820D3

Q35354287-1A8D0BF0-1630-4670-A50F-6E569CA4C438

Q35354287-2003E38C-CBEF-4B9D-936D-32FB4261BA67

Q35354287-21E91D34-7CD1-4A7C-8D70-702CC42B81C8

Q35354287-233E1C2E-FC90-496A-8E16-3E6D7F72EA86

Q35354287-25C3B9C9-8113-4A77-AF82-F381B95D31A0

Q35354287-263A81F6-09CC-4309-AB01-7788B6145E69

Q35354287-26FECE48-F133-4CCD-AFB1-3A759FDA4526

P304

Q35354287-EF827F40-CC52-4AD4-A39A-B9DEB6B2FAD3

P31

Q35354287-3278CEF2-342F-4A52-9011-B4E6466BE696

P356

Q35354287-91949826-49F2-4E03-8BC9-4C872F32182F

P407

Q35354287-9E9E30B1-7546-4E9B-86CA-BB2A9A4A972E

P433

Q35354287-7697D339-F4A4-4AE0-8130-81F82BF2E5D8

P478

Q35354287-B082179F-C46C-400C-8B57-C81B32A272B9

P50

Q35354287-F72E50DE-5FC7-4118-92D2-C8567D289C08

P577

Q35354287-03096B3B-A7B4-4800-9EC3-FAB6A9E3B964

P698

Q35354287-A2AF7FED-14C2-405D-9D06-3AA2227D86DE

P356

07853899209149951

P1433

Annals of Medicine

P1476

Evaluation of growth hormone secretion and treatment

@en

P2093

Tapanainen P

http://www.w3.org/2001/XMLSchema#string

P2860

Growth hormone secretion during sleep

A specific growth hormone-binding protein in human plasma: initial characterization

Growth hormone releasing factor, somatocrinin, releases pituitary growth hormone in vitro

Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation.

Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in man

Treatment of growth hormone deficiency.

Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone.

Use of insulin-like growth factor-binding protein 3 for the evaluation of growth disorders.

Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with growth hormone deficiency, low birthweight, inherited smallness, Turner's syndrome, and other complaints.

Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor.

P304

237-247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/07853899209149951

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

P577

1992-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1389086

http://www.w3.org/2001/XMLSchema#string